Bitcoin Updates: Veteran Bitcoin Holders Swap HODLing for ETFs as Digital Gold Attracts More Institutional Interest
- Bitcoin OGs increasingly sell holdings to ETFs for tax deferrals and institutional legitimacy, signaling market maturation. - U.S. tax advantages enable long-term holders to optimize returns amid slower growth, shifting from "HODL" to strategic diversification into AI/DePIN. - ETF outflows pressure Bitcoin's price, yet on-chain data shows long-term holders remain net accumulators, reflecting tactical repositioning. - Institutional adoption grows as Bitcoin gains recognition as inflation hedge, with Black
Bitcoin Long-Term Investors Turn to ETFs for Tax Efficiency and Portfolio Expansion
Early Bitcoin adopters are increasingly offloading parts of their assets to benefit from the tax perks and institutional credibility provided by exchange-traded funds (ETFs), indicating a maturing crypto landscape. Experts point out that this movement marks a shift from speculative holding to more calculated portfolio strategies as
This trend is largely fueled by the specific tax advantages ETFs offer under U.S. law, enabling investors to delay capital gains taxes by reacquiring Bitcoin through ETF channels, as outlined in the same
The rise of ETFs has paralleled historic withdrawals from leading funds. BlackRock’s iShares Bitcoin Trust (IBIT) saw $570 million in redemptions during a single week in late October 2025, the highest in nine months, according to a
Even with these withdrawals, blockchain data shows that long-term investors continue to accumulate Bitcoin overall, a trend that matches previous periods of market consolidation, as highlighted in the
This development also points to a larger transformation in the industry. As Bitcoin’s speculative appeal fades, its reputation as a safeguard against inflation and economic instability is gaining traction among institutions, as noted in the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Solana's Value Soars: Key Factors Fueling Investor Confidence Toward the End of 2025
- Solana (SOL) surges in late 2025 due to infrastructure upgrades, institutional adoption, and strong on-chain metrics. - Firedancer validator client boosts TPS to 1M+, while Alpenglow aims for sub-second finality, enhancing scalability for real-time finance. - Institutional holdings of SOL jump 841% to 16M tokens, with Visa and R3 partnerships validating its role in cross-chain global finance. - Network records 17.2M active addresses and 543M weekly transactions, maintaining 8% DeFi market share despite b
Uniswap Latest Updates Today:
- UNI token surged over 40% to $10+ as Uniswap Labs and Foundation proposed "UNIfication" to distribute protocol fees to holders via token burns and a "token jar." - The plan includes burning 100M UNI ($800M) and allocating 16.7%-25% of v2/v3 pool fees to holders, merging the Foundation into Labs to streamline operations. - Market reactions saw UNI jump 30% in a day, reaching $10.50, with a $7.19B market cap, driven by optimism over DeFi fee capture and DUNA approval easing regulatory concerns. - Critics w
Bitcoin Leverage Liquidations Spike in November 2025: A Warning Story for Crypto Derivatives Traders
- November 2025 saw $20B+ in crypto derivatives liquidated as Bitcoin fell below $100,000, driven by 1001:1 leverage and automated stop-loss mechanisms. - Leverage-driven cascading liquidations pushed Ethereum to four-month lows and exposed systemic risks in unregulated platforms like Hyperliquid and Aster. - Regulators proposed CFTC/SEC role clarifications and domestic leveraged trading, but experts warn structural imbalances persist despite growing retail risk awareness. - Institutional investors shifted
Bitcoin News Update: Propanc’s Cryptocurrency-Driven Cancer Initiative Encounters Doubt from Investors, Stock Falls by 10.5%
- Australia-based Propanc Biopharma secured up to $100M from Hexstone Capital to build a crypto treasury and advance its cancer therapy PRP, targeting first-in-human trials by 2026. - The funding strategy reflects a growing trend in biotech to leverage crypto assets for non-dilutive capital, with Hexstone’s portfolio including Bitcoin , Ether , and Solana . - CEO James Nathanielsz called the move "transformative," aiming to diversify Propanc’s assets while tying capital to clinical milestones, though share
Trending news
MoreCrypto prices
More
